Search

Ganapathy, M., R. Ghosh, X. Jianping, X. Zhang, R. Bedolla, J. Schoolfield, I. T. Yeh, D. A. Troyer, A. F. Olumi, and A. P. Kumar. 2009. Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model.

Rodríguez, D., and A. F. Olumi. 2012. Management of Spermatic Cord Tumors: A Rare Urologic Malignancy.

Bechis, S. K., A. G. Otsetov, R. Ge, and A. F. Olumi. 2014. Personalized Medicine for the Management of Benign Prostatic Hyperplasia.

Xu, R., N. Horick, F. J. McGovern, D. M. Dahl, A. S. Feldman, M. L. Blute, A. F. Olumi, and M. D. Michaelson. 2014. Prognostic Significance of Indeterminate Lung Nodules in Renal Cell Carcinoma.

Bechis, S. K., A. G. Otsetov, R. Ge, Z. Wang, M. G. Vangel, C. L. Wu, S. Tabatabaei, and A. F. Olumi. 2015. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.

Cornejo, K. M., M. Lu, P. Yang, S. Wu, C. Cai, W. D. Zhong, A. Olumi, R. H. Young, and C. L. Wu. 2015. Succinate Dehydrogenase B: A New Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Liu, Q., L. Gheorghiu, M. Drumm, R. Clayman, A. Eidelman, M. F. Wszolek, A. Olumi, et al. 2018. PARP-1 Inhibition With or Without Ionizing Radiation Confers Reactive Oxygen Species-Mediated Cytotoxicity Preferentially to Cancer Cells With Mutant TP53.

Wu, S., S. X. Lin, G. J. Wirth, M. Lu, J. Lu, A. O. Subtelny, Z. Wang, D. M. Dahl, A. F. Olumi, and C. L. Wu. 2019. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.

McConkey, D., C. J. M. Best, J. A. Gumminger, and A. F. Olumi. 2021. Advancing Bladder Preservation: Biomarkers, Decision-Making, and Therapy.

Monfared, S., A. Fleishman, R. Korets, P. Chang, A. Wagner, G. Bubley, I. Kaplan, A. F. Olumi, and B. Gershman. 2021. The Impact of Pretreatment PSA on Risk Stratification in Men With Gleason 6 Prostate Cancer: Implications for Active Surveillance.